BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24680127)

  • 1. The risk of developing a second primary cancer in melanoma patients: a comprehensive review of the literature and meta-analysis.
    Caini S; Boniol M; Botteri E; Tosti G; Bazolli B; Russell-Edu W; Giusti F; Testori A; Gandini S
    J Dermatol Sci; 2014 Jul; 75(1):3-9. PubMed ID: 24680127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
    Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
    J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
    Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
    J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Second Primary Cancer in Survivors of In Situ Melanoma.
    Kimlin MG; Youlden DR; Brodie AM; DiSipio T; Youl P; Nair-Shalliker V; Baade PD
    J Invest Dermatol; 2019 Apr; 139(4):842-847. PubMed ID: 30423330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy.
    Caini S; Radice D; Tosti G; Spadola G; Cocorocchio E; Ferrucci PF; Testori A; Pennacchioli E; Fargnoli MC; Palli D; Bazolli B; Botteri E; Gandini S
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1491-6. PubMed ID: 26990937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Need For Improved Skin Cancer Surveillance in Pediatric Cancer Survivors.
    Sharma D; Lee T; Friedman AJ; Redbord KP
    Am J Clin Dermatol; 2017 Apr; 18(2):165-168. PubMed ID: 27943084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
    Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
    Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.
    Kurlander DE; Martires KJ; Chen Y; Barnholtz-Sloan JS; Bordeaux JS
    J Am Acad Dermatol; 2013 May; 68(5):790-6. PubMed ID: 23261548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of second primary malignancies in patients with cutaneous melanoma.
    Schmid-Wendtner MH; Baumert J; Wendtner CM; Plewig G; Volkenandt M
    Br J Dermatol; 2001 Dec; 145(6):981-5. PubMed ID: 11899153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
    Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
    Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
    Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
    Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
    Goyal A; O'Leary D; Goyal K; Patel K; Pearson D; Janakiram M
    J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).
    Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Pannozzo F
    Melanoma Res; 2008 Jun; 18(3):230-4. PubMed ID: 18477899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.
    Uliasz A; Lebwohl M
    Int J Dermatol; 2007 Jun; 46(6):575-7. PubMed ID: 17550554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifetime risks of common cancers among retinoblastoma survivors.
    Fletcher O; Easton D; Anderson K; Gilham C; Jay M; Peto J
    J Natl Cancer Inst; 2004 Mar; 96(5):357-63. PubMed ID: 14996857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of second primary cancers after a diagnosis of melanoma.
    Bradford PT; Freedman DM; Goldstein AM; Tucker MA
    Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.
    van der Leest RJ; Liu L; Coebergh JW; Neumann HA; Mooi WJ; Nijsten T; de Vries E
    Br J Dermatol; 2012 Dec; 167(6):1321-30. PubMed ID: 22759226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.